- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07701694
Functional Evaluation in Patients With Urea Cycle Disorders (UCD) During a Driving Task
Cognitive and Motor Function Examination in Patients With Urea Cycle Disorders (UCD) During a Driving Task Using Functional Near Infrared Spectroscopy (fNIRS)
Visão geral do estudo
Status
Condições
Descrição detalhada
Primary Objective
- To use fNIRS to study brain functional behavior in subjects with UCD by measuring the changes in HbO, HbR and HbT concentrations versus healthy control volunteers during the baseline driving task on the left and right prefrontal cortex (LPFC, RPFC).
Secondary Objective
- To include other cortical regions such as temporal and occipital regions, to investigate the neurocognitive changes in these regions which may or may not change with driving. Thus, we will measure changes in HbO, HbR and HbT concentrations during the baseline driving task in four more brain regions (left and right parietal and occipital regions, LPA, RPA, LOL, ROL).
This is a non-therapeutic, non-interventional study in which brain fNIRS (functional near-infrared spectroscopy) measures will be compared under simulated driving conditions between patients with UCD vs. age and sex-matched control participants.
Participants who agree to participate will have Information about their medical history collected, have a basic neurological exam and answer questions about their health, diet, and driving habits. They will complete some simple thinking and memory tests. These tests will help investigators understand skills like memory, attention, and problem-solving. Participants will also wear a soft cap with small sensors called an fNIRS (functional near-infrared spectroscopy) device while they complete a driving simulator activity. This cap is noninvasive and measures how the brain uses oxygen while they drive in the simulator.
All study activities will be completed on the day of enrollment.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Jean Laboe, RN
- Número de telefone: 901-595-1693
- E-mail: jean.laboe@stjude.org
Locais de estudo
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38105
- Recrutamento
- St. Jude Children's Research Hospital
-
Contato:
- Jean Laboe, RN
- Número de telefone: 901-595-1693
- E-mail: jean.laboe@stjude.org
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Individuals 16 to 40 years with molecular or biochemical confirmation of a urea cycle disorder.
- Healthy individuals will serve as an age and sex matched comparison group. Active driver's license for at least 6 months
- Read and understand English. as the tasks have not been validated in other languages
- IQ >=70.
Exclusion Criteria:
- Skin disease that affects the scalp
- Past or present vascular disease
- Head trauma with loss of consciousness in the last year or evidence of cognitive impairment due to and persisting after head trauma
- Motor movement disorder which may cause excessive movement or impede use of the steering wheel and/or pedal
- Premature birth or birth before 32 weeks of gestation
- The participant is taking a stimulant or antidepressant
- Allergy to any component of the device, although expected to be rare
- History of psychosis
- Self-reported motion or cyber sickness
- Self-reported illicit substance use
- Vision disorder
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
UCD group
Participants with urea cycle disorders (UCD) who meet the Eligibility Criteria and consent to participate
|
|
Control group
Healthy controls who meet the Eligibility Criteria and consent to participate
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in Oxyhemoglobin (HbO), Deoxyhemoglobin (HbR) and Total Hemoglobin (HbT) concentrations in the right and left prefrontal cortex in participants with urea cycle disorders (UCD) compared to healthy control volunteers
Prazo: Day 1, during driving simulator task
|
Investigators will compare prefrontal cortex hemoglobin concentrations during low cognitive load between patients with UCD and healthy age and sex matched control participants using functional near-infrared spectroscopy (fNIRS).
Mean values of hemoglobin concentration differences on the right and left prefrontal cortex between individuals, with and without UCD, during the low cognitive load task will be calculated and compared using two sample t-tests (for normally distributed data) or Wilcoxon rank sum tests (for nonnormally distributed data).
P values will be adjusted for multiple comparisons using the Bonferroni method.
|
Day 1, during driving simulator task
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in HbO, HbR and HbT concentrations in the left and right parietal and occipital brain regions in participants with urea cycle disorders (UCD) compared to healthy control volunteers
Prazo: Day 1, during driving simulator task
|
Investigators will compare left and right parietal and occipital regions hemoglobin concentrations during low cognitive load between patients with UCD and healthy age and sex matched control participants using functional near-infrared spectroscopy (fNIRS).
Mean values of hemoglobin concentration differences on the left and right parietal and occipital regions between individuals, with and without UCD, during the low cognitive load task will be calculated and compared using two sample t-tests (for normally distributed data) or Wilcoxon rank sum tests (for nonnormally distributed data).
P values will be adjusted for multiple comparisons using the Bonferroni method.
|
Day 1, during driving simulator task
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Andrea Gropman, M.D., St. Jude Children's Research Hospital
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças Cerebrais
- Doenças do Sistema Nervoso Central
- Doenças do Sistema Nervoso
- Metabolismo, Erros Inatos
- Doenças Genéticas, Congênitas
- Doenças Metabólicas
- Doenças Cerebrais Metabólicas Inatas
- Doenças Cerebrais Metabólicas
- Metabolismo de Aminoácidos, Erros Inatos
- Doenças e Anormalidades Congênitas, Hereditárias e Neonatais
- Doenças Nutricionais e Metabólicas
- Distúrbios Inatos do Ciclo da Uréia
Outros números de identificação do estudo
- DRIVEUCD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .